ArticleJournal of immunology (Baltimore, Md. : 1950)2015

Alkylating agent melphalan augments the efficacy of adoptive immunotherapy using tumor-specific CD4+ T cells.

Xiaoyun Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.